Is there an alternative treatment option for patients with primary aldosteronism?.
10.3760/cma.j.cn112148-20230724-00020
- Author:
Zhi Ming ZHU
1
;
Hao WU
1
Author Information
1. Department of Hypertension and Endocrinology, Center for Hypertension and Cardiometabolic Diseases, Daping Hospital, Army Medical University, Chongqing Institute of Hypertension, Chongqing 400042, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Hyperaldosteronism/therapy*;
Aldosterone;
Hypertension
- From:
Chinese Journal of Cardiology
2023;51(11):1126-1129
- CountryChina
- Language:Chinese
